Vetophage
Vetophage is dedicated to fighting antimicrobial resistance in animal health through innovative solutions based on phage proteins, endolysins, and phage capture proteins. The company develops rapid diagnostic tools and therapeutic solutions to manage bacterial infections in animals, aiming to reduce the reliance on antibiotics and promote sustainable health practices. With a strong focus on research, collaboration, and technological development, Vetophage is actively involved in projects for early detection and treatment of bacterial diseases such as bovine mastitis and canine pyoderma.
Industries
Nr. of Employees
small (1-50)
Vetophage
Lyon, Rhone-Alpes, France, Europe
Products
LabMastis S.A
A rapid, field-deployable diagnostic kit using phage-derived capture proteins for detection of Staphylococcus aureus in milk and environmental samples; designed for use by veterinarians and laboratories without specialized equipment.
Endolysin-based therapeutic candidate for canine pyoderma
A veterinary therapeutic in development that uses endolysin proteins to reduce bacterial load in skin infections and support lesion healing while preserving the native microbiome; currently in preclinical/early development.
Banque de
Plateforme technique et banque de protéines de phages (endolysines) mises à disposition des industriels sous forme de licence ou d'achat pour le développement de nouveaux produits antibactériens et de détection.
Bovine Mastitis Diagnostic Platform
A diagnostic project focused on the early detection of bovine mastitis using highly specific phage proteins for targeted management in the dairy industry.
Phagothèque
Vast collection of reference phages targeting major animal health and production pathogens.
Specific diagnostic tools for managing the health of animal populations
Tailored diagnostic tools leveraging phage proteins to detect bacteria and manage animal population health.
LabMastis S.A
A rapid, field-deployable diagnostic kit using phage-derived capture proteins for detection of Staphylococcus aureus in milk and environmental samples; designed for use by veterinarians and laboratories without specialized equipment.
Endolysin-based therapeutic candidate for canine pyoderma
A veterinary therapeutic in development that uses endolysin proteins to reduce bacterial load in skin infections and support lesion healing while preserving the native microbiome; currently in preclinical/early development.
Banque de
Plateforme technique et banque de protéines de phages (endolysines) mises à disposition des industriels sous forme de licence ou d'achat pour le développement de nouveaux produits antibactériens et de détection.
Bovine Mastitis Diagnostic Platform
A diagnostic project focused on the early detection of bovine mastitis using highly specific phage proteins for targeted management in the dairy industry.
Phagothèque
Vast collection of reference phages targeting major animal health and production pathogens.
Specific diagnostic tools for managing the health of animal populations
Tailored diagnostic tools leveraging phage proteins to detect bacteria and manage animal population health.
Services
Making collections of phages and phage-derived proteins available to manufacturers under licensing or purchase arrangements.
Search and development of phages or phage proteins tailored to partner specifications, including identification and initial characterization.
Laboratory testing services to assess antibacterial activity of phages and endolysins on requested bacterial targets.
Design and execution of validation studies for detection kits and therapeutic concepts including independent laboratory and field studies.
Collaborative development agreements and partnerships to progress diagnostic or therapeutic candidates to market.
Sale of rapid diagnostic kits for veterinary use, with order/quote workflow and supporting documentation (user guides, safety data sheets).
Making collections of phages and phage-derived proteins available to manufacturers under licensing or purchase arrangements.
Search and development of phages or phage proteins tailored to partner specifications, including identification and initial characterization.
Laboratory testing services to assess antibacterial activity of phages and endolysins on requested bacterial targets.
Design and execution of validation studies for detection kits and therapeutic concepts including independent laboratory and field studies.
Collaborative development agreements and partnerships to progress diagnostic or therapeutic candidates to market.
Sale of rapid diagnostic kits for veterinary use, with order/quote workflow and supporting documentation (user guides, safety data sheets).
Expertise Areas
- Phage and phage-protein discovery
- Diagnostic assay development for bacterial pathogens
- Veterinary therapeutic development (endolysin-based)
- Biobanking of biological reagents
Key Technologies
- Phage isolation and genotyping
- Endolysins (phage-derived lytic enzymes)
- Phage-derived capture proteins
- Recombinant protein expression
News & Updates
Presentation of the LabMastis® SA diagnostic test for Staphylococcus aureus in milk at the Swiss Veterinary Days in Basel, April 2024.
An article highlighting Vetophage's efforts to develop phage-based solutions to combat bacterial infections in animals, including a new treatment for bovine mastitis.
Vetophage was awarded the INPI 2022 Start-up Trophy for its innovative solutions in animal health and bacterial detection.
Presentation of the LabMastis® SA diagnostic test for Staphylococcus aureus in milk at the Swiss Veterinary Days in Basel, April 2024.
An article highlighting Vetophage's efforts to develop phage-based solutions to combat bacterial infections in animals, including a new treatment for bovine mastitis.
Vetophage was awarded the INPI 2022 Start-up Trophy for its innovative solutions in animal health and bacterial detection.